Erich A. Leeser

Array ( [id] => 3726567 [patent_doc_number] => 05670380 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-23 [patent_title] => 'Assay for fetal thyroid function' [patent_app_type] => 1 [patent_app_number] => 8/273104 [patent_app_country] => US [patent_app_date] => 1994-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5620 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 167 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/670/05670380.pdf [firstpage_image] =>[orig_patent_app_number] => 273104 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3834696 [patent_doc_number] => 05712370 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-27 [patent_title] => 'Erythropoietin (EPO) peptides and antibodies directed against these' [patent_app_type] => 1 [patent_app_number] => 8/267539 [patent_app_country] => US [patent_app_date] => 1994-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 4564 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/712/05712370.pdf [firstpage_image] =>[orig_patent_app_number] => 267539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3692837 [patent_doc_number] => 05679582 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-21 [patent_title] => 'Screening method for identifying ligands for target proteins' [patent_app_type] => 1 [patent_app_number] => 8/263923 [patent_app_country] => US [patent_app_date] => 1994-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 11 [patent_no_of_words] => 10755 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/679/05679582.pdf [firstpage_image] =>[orig_patent_app_number] => 263923 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3730269 [patent_doc_number] => 05670626 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-23 [patent_title] => 'Allergen-specific human IgA monoclonal antibodies for mucosal administration' [patent_app_type] => 1 [patent_app_number] => 8/263258 [patent_app_country] => US [patent_app_date] => 1994-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6971 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/670/05670626.pdf [firstpage_image] =>[orig_patent_app_number] => 263258 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4023490 [patent_doc_number] => 05882945 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-16 [patent_title] => 'Heterodimeric T lymphocyte receptor' [patent_app_type] => 1 [patent_app_number] => 8/262827 [patent_app_country] => US [patent_app_date] => 1994-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 14 [patent_no_of_words] => 7402 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/882/05882945.pdf [firstpage_image] =>[orig_patent_app_number] => 262827 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3650589 [patent_doc_number] => 05639863 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-17 [patent_title] => 'Human monoclonal antibodies specific to cell cycle independent glioma surface antigen' [patent_app_type] => 1 [patent_app_number] => 8/264093 [patent_app_country] => US [patent_app_date] => 1994-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 8989 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/639/05639863.pdf [firstpage_image] =>[orig_patent_app_number] => 264093 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4032870 [patent_doc_number] => 05856112 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-05 [patent_title] => 'Method for selectively inducing biomarker expression in urologic tumor tissue for diagnosis and treatment thereof' [patent_app_type] => 1 [patent_app_number] => 8/260554 [patent_app_country] => US [patent_app_date] => 1994-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 15 [patent_no_of_words] => 9214 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/856/05856112.pdf [firstpage_image] =>[orig_patent_app_number] => 260554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3688982 [patent_doc_number] => 05679320 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-21 [patent_title] => 'Fibrin binding domain polypeptides and uses and methods of producing same' [patent_app_type] => 1 [patent_app_number] => 8/259569 [patent_app_country] => US [patent_app_date] => 1994-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 66 [patent_figures_cnt] => 82 [patent_no_of_words] => 34919 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/679/05679320.pdf [firstpage_image] =>[orig_patent_app_number] => 259569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3678615 [patent_doc_number] => 05632982 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-27 [patent_title] => 'Cytotoxic enhancement of TNF with copper' [patent_app_type] => 1 [patent_app_number] => 8/255265 [patent_app_country] => US [patent_app_date] => 1994-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5829 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/632/05632982.pdf [firstpage_image] =>[orig_patent_app_number] => 255265 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3506778 [patent_doc_number] => 05562907 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-08 [patent_title] => 'Method to prevent side-effects and insensitivity to the therapeutic uses of toxins' [patent_app_type] => 1 [patent_app_number] => 8/254238 [patent_app_country] => US [patent_app_date] => 1994-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12210 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/562/05562907.pdf [firstpage_image] =>[orig_patent_app_number] => 254238 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3837318 [patent_doc_number] => 05707624 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-13 [patent_title] => 'Treatment of Kaposi\'s sarcoma by inhibition of scatter factor' [patent_app_type] => 1 [patent_app_number] => 8/253728 [patent_app_country] => US [patent_app_date] => 1994-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 20 [patent_no_of_words] => 13890 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/707/05707624.pdf [firstpage_image] =>[orig_patent_app_number] => 253728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3695488 [patent_doc_number] => 05595915 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-21 [patent_title] => 'Method of determining antigenically active amino acid sequences' [patent_app_type] => 1 [patent_app_number] => 8/252399 [patent_app_country] => US [patent_app_date] => 1994-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 11 [patent_no_of_words] => 3866 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/595/05595915.pdf [firstpage_image] =>[orig_patent_app_number] => 252399 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3621336 [patent_doc_number] => 05601989 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-11 [patent_title] => 'Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy' [patent_app_type] => 1 [patent_app_number] => 8/251590 [patent_app_country] => US [patent_app_date] => 1994-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 10108 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/601/05601989.pdf [firstpage_image] =>[orig_patent_app_number] => 251590 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3662480 [patent_doc_number] => 05667981 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-16 [patent_title] => 'Diagnostics and treatments for cancers expressing tyrosine phosphorylated CRKL protein' [patent_app_type] => 1 [patent_app_number] => 8/242513 [patent_app_country] => US [patent_app_date] => 1994-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 16 [patent_no_of_words] => 9903 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/667/05667981.pdf [firstpage_image] =>[orig_patent_app_number] => 242513 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3624683 [patent_doc_number] => 05620901 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-15 [patent_title] => 'Determination of concentration by affinity titration' [patent_app_type] => 1 [patent_app_number] => 8/238379 [patent_app_country] => US [patent_app_date] => 1994-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 3791 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/620/05620901.pdf [firstpage_image] =>[orig_patent_app_number] => 238379 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3708076 [patent_doc_number] => 05654403 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-05 [patent_title] => 'Immunoglobulins stabilized with a chelator of copper ions' [patent_app_type] => 1 [patent_app_number] => 8/232127 [patent_app_country] => US [patent_app_date] => 1994-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5147 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/654/05654403.pdf [firstpage_image] =>[orig_patent_app_number] => 232127 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3537395 [patent_doc_number] => 05494799 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-02-27 [patent_title] => 'In vitro assay for detecting cell-mediated immune responses' [patent_app_type] => 1 [patent_app_number] => 8/230373 [patent_app_country] => US [patent_app_date] => 1994-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4308 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/494/05494799.pdf [firstpage_image] =>[orig_patent_app_number] => 230373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3729537 [patent_doc_number] => 05635388 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-03 [patent_title] => 'Agonist antibodies against the flk2/flt3 receptor and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/222299 [patent_app_country] => US [patent_app_date] => 1994-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 12 [patent_no_of_words] => 16072 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/635/05635388.pdf [firstpage_image] =>[orig_patent_app_number] => 222299 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3847366 [patent_doc_number] => 05719063 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-17 [patent_title] => 'Multiplex immunoassay system' [patent_app_type] => 1 [patent_app_number] => 8/222113 [patent_app_country] => US [patent_app_date] => 1994-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5845 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 167 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/719/05719063.pdf [firstpage_image] =>[orig_patent_app_number] => 222113 [rel_patent_id] =>[rel_patent_doc_number] =>)